SMH
NVAX icon

Sanders Morris Harris’s Novavax NVAX Stock Holding History

Sanders Morris Harris’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,700
Closed -$243K – 329
2021
Q4 		$243K Hold
1,700
– – 0.04% 256
2021
Q3 		$352K Hold
1,700
– – 0.06% 222
2021
Q2 		$361K Hold
1,700
– – 0.07% 224
2021
Q1 		$308K Buy
+1,700
New +$339K 0.07% 223

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sanders Morris Harris's NVAX Position: Q1 2022 in Review

Sanders Morris Harris sold out of Novavax (NVAX) in Q1 2022, closing a stake of 1,700 shares — an estimated $243K sold.

Sanders Morris Harris first reported a position in NVAX in Q1 2021 and held it in 4 quarters. The position peaked at $361K in Q2 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Sanders Morris Harris reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Sanders Morris Harris sold 1,700 Novavax shares in Q1 2022, an estimated $243K.
  • Sanders Morris Harris first reported a position in Novavax in Q1 2021 and held it in 4 quarters.
  • Sanders Morris Harris's Novavax position peaked at $361K in Q2 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Sanders Morris Harris's 13F filing for Q1 2022, filed 11 Apr 2022.